News

Watch Video BOSTON — Dana-Farber Cancer Institute has launched a new clinical trial aimed at detecting cancer earlier among U.S. veterans. The study, called the Sentinel Study, plans to enroll 1,500 veterans and is supported in part by a grant from the Department of Defense. By leveraging multi-cancer early detection (MCED) blood tests, the trial aims to identify cancer signals long before symptoms appear, offering veterans a potentially life-saving advantage. Veterans face